Hypertension (high blood pressure) decisions — 2025

The Board denied evaluations in excess of 10 percent for neuropathy and a compensable rating for hypertension, as well as an evaluation in excess of 20 percent for diabetes mellitus type II.

The Board grants service connection for hypertension as secondary to the Veteran's service-connected hyperthyroidism.

The Board granted service connection for adenocarcinoma of the lung, ischemic cardiomyopathy, and hypertension based on herbicide exposure in the demilitarized zone (DMZ) under the PACT Act. The claim for thyroid cancer was denied.

The Board denied the Veteran's claim for service connection for hypertension, finding no evidence of an in-service injury or disease and a prolonged period without complaint or diagnosis.

The Board granted ratings of 30 to 40 percent for various diabetic neuropathies and restored a 10 percent rating for hypertension, while denying an increased rating for diabetes mellitus type II.

The Board granted service connection for hypertension as secondary to the service-connected Type II diabetes mellitus but denied service connection for right knee arthritis.

The Board remands the claim for a VA hypertension examination to determine the level of severity associated with the Veteran's service-connected hypertension.

The Board remands the claims for service connection for various conditions, including right shoulder strain, left shoulder disorder, right knee disorder, left knee minimal degenerative joint disease with patellar tendinitis and bursitis, vertigo, congestive heart failure, and hypertension, to correct duty-to-assist errors.

The Veteran is granted a total disability rating based on individual unemployability (TDIU) and an effective date of August 13, 2019, for the grant of Special Monthly Compensation (SMC) based on the need for aid and attendance.

The Board denied the Veteran's claim for an increased rating for service-connected hypertension, as the evidence did not show a diastolic pressure predominantly 100 or more or systolic pressure predominantly 160 or more.

The Board remands the claims for service connection for hypertension and obstructive sleep apnea to obtain additional medical opinions.

The Board granted service connection for hypertension, Parkinson's disease, cryptococcal infection, and sarcoidosis as secondary to the cryptococcal infection. COPD was also granted as secondary to both cryptococcal infection and Parkinson's disease.

The Board denied the petitions to readjudicate the claims for entitlement to service connection for right shoulder calcific tendinitis and hypertrophic changes in acromioclavicular joint and hypertension as there was no new and relevant evidence submitted since the prior denial.

The Board granted service connection for coronary artery disease, hypertension, and chronic lymphocytic leukemia but denied it for hypothyroidism.

The Board denied service connection for a left meniscus tear, right knee instability, chronic sinusitis or other condition of the nose, throat, larynx and pharynx, diabetes, type 1 or type 2, hypertension (high blood pressure), tinnitus, and visual impairment, including blurry vision, blindness and double vision.

The Board denied an initial rating in excess of 10 percent for hypertension and granted a 10 percent rating for gastroesophageal reflux disease (GERD).

The Board granted service connection for diabetes mellitus, type II, a heart condition, and hypertension as secondary to the Veteran's service-connected acquired psychiatric disorder.

The appeal of the November 2024 rating decision denying a compensable rating for hypertension was dismissed due to an impermissible concurrent election.

The Board granted service connection for hypertension as it is proximately caused by the Veteran's service-connected degenerative arthritis osteophyte vertebrae L5.

The Board granted service connection for prostate cancer, hypertension, erectile dysfunction, and voiding dysfunction based on presumptive exposure to herbicide agents during the Veteran's service in Thailand.